Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Learn More About What It Takes To Achieve URAC Accreditation
Genex Services is a leader in utilization review (UR) and has an advanced position to meet the requirements of California Senate Bill 1160, particu
Workers' Comp
News Release
Genex Develops Ebola Guidelines for the Workers' Comp Industry
Protocols among first specifically focused on infected workersDecember 17, 2014 – Wayne, Pa. – As health care experts wor
Benefits Magazine
Article
Benefits Magazine: 7 Questions Toward More Effective Workers' Comp Programs
WorkCompWire
Article
3 For NWCDC: Ron Skrocki of GENEX Services
Workers' Comp
Article
WorkCompWire: Archie Anderson: Time for a Fresh Look at the Independent Medical Exam
For years the Independent Medical Exam (IME) has been a staple in the workers’ compensation claims resolution arsenal.
Workers' Comp
News Release
Genex Services Acquires Leading Case Management Firm M Hayes
Genex Services Acquires Leading Case Management Firm M Hayes Acquisition extends Genex's position as largest case management provider in nation